Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1285 |
---|---|
Product Name | Anti-Human CD20 Recombinant Antibody(Ocaratuzumab) |
Molecular Name | Ocaratuzumab |
Alias | Anti-CD20 Recombinant Antibody, Research Grade Ocaratuzumab |
CAS Number | 1169956-08-4 |
Target | CD20[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
Buffer | PBS, pH7.5 |
Background | Ocaratuzumab (AME-133v, LY2469298) is a humanized monoclonal antibody designed for the treatment of cancer and autoimmune disorders. The antibody is engineered for enhanced affinity to the CD20 antigen on B-lymphocytes, increased antibody-dependent cell-mediated cytotoxicity (ADCC), and for improved treatment of low-affinity FcγRIIIa allotypes. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |